InvestorsHub Logo
Followers 209
Posts 32160
Boards Moderated 1
Alias Born 06/30/2009

Re: PJ007 post# 385555

Thursday, 12/02/2021 9:28:08 AM

Thursday, December 02, 2021 9:28:08 AM

Post# of 403039
"However it did show a difference at a higher dosage during compassionate use"
The IPIX CEO didn't say that, did he? Nope. He knows better...

"this data will soon be published"
He didn't say that either. He knows that people are reading every word he says.

Here's EVERYTHING he has said about the recent compassionate use efforts:
"The Company is further encouraged by compassionate use of Brilacidin, which involved the treatment of extremely critically-ill patients who had exhausted all other therapeutic options. Compassionate use cases comprised Brilacidin being administered over a longer duration (up to 10 days) than in the Phase 2 COVID-19 trial (3 and 5 day dosing), with some patients also receiving higher and more frequent dosing (two doses every 24 hours). Patient data is planned to be compiled and evaluated, which may shed additional light on Brilacidin’s treatment potential in COVID-19."

Where does it say that B "did show a difference at a higher dosage during compassionate use"?
Where does it say "this data will soon be published"?

It doesn't say either of those things....if they were true he surely would. He knows better. People are watching.


As my dear old grandfather Litvak said (just before they swung the trap), he said "You can't cheat an honest man. Never give a sucker an even break or smarten up a chump."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News